| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer
|
Poon, Darren M. C.
|
|
|
149 |
2 |
p. 841-850
|
artikel
|
| 2 |
Anti-CD20–atezolizumab–polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma
|
Topp, Max S.
|
|
|
149 |
2 |
p. 811-817
|
artikel
|
| 3 |
Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry data
|
Engel, Jutta
|
|
|
149 |
2 |
p. 721-735
|
artikel
|
| 4 |
Burnout among German oncologists: a cross-sectional study in cooperation with the Arbeitsgemeinschaft Internistische Onkologie Quality of Life Working Group
|
Helaß, Madeleine
|
|
|
149 |
2 |
p. 765-777
|
artikel
|
| 5 |
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
|
Arndt, Volker
|
|
|
149 |
2 |
p. 913-919
|
artikel
|
| 6 |
Case report: identification of EGFR R776H and FANCE R381H germline mutations in a patient with multiple pulmonary nodules
|
Wu, Zhenzhen
|
|
|
149 |
2 |
p. 921-927
|
artikel
|
| 7 |
Clinical features and response to systemic therapy in NRAS-mutant Chinese melanoma patients
|
Wang, Jiuhong
|
|
|
149 |
2 |
p. 701-708
|
artikel
|
| 8 |
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years
|
Kürzel, Sabine
|
|
|
149 |
2 |
p. 929-931
|
artikel
|
| 9 |
Enhancing the immune effect of oHSV-1 therapy through TLR3 signaling in uveal melanoma
|
Liu, Sisi
|
|
|
149 |
2 |
p. 901-912
|
artikel
|
| 10 |
Establishing a metastasis-related diagnosis and prognosis model for lung adenocarcinoma through CRISPR library and TCGA database
|
Shao, Fanggui
|
|
|
149 |
2 |
p. 885-899
|
artikel
|
| 11 |
Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
|
Tan, Wei
|
|
|
149 |
2 |
p. 593-608
|
artikel
|
| 12 |
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria
|
Sun, Qi
|
|
|
149 |
2 |
p. 579-592
|
artikel
|
| 13 |
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events
|
Jiang, Ning
|
|
|
149 |
2 |
p. 737-747
|
artikel
|
| 14 |
Hyperbaric oxygen enhanced the chemotherapy of mitochondrial targeting molecule IR-780 in bladder cancer
|
Shen, Chongxing
|
|
|
149 |
2 |
p. 683-699
|
artikel
|
| 15 |
Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development
|
Li, Yi-Fei
|
|
|
149 |
2 |
p. 623-637
|
artikel
|
| 16 |
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial
|
Sun, Chao
|
|
|
149 |
2 |
p. 819-831
|
artikel
|
| 17 |
MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors
|
Schönberger, Stefan
|
|
|
149 |
2 |
p. 791-802
|
artikel
|
| 18 |
Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer
|
Hu, Po
|
|
|
149 |
2 |
p. 553-566
|
artikel
|
| 19 |
NOD2 inhibits the proliferation of esophageal adenocarcinoma cells through autophagy
|
Li, Xiaozhi
|
|
|
149 |
2 |
p. 639-652
|
artikel
|
| 20 |
Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team
|
Fan, Christopher
|
|
|
149 |
2 |
p. 877-883
|
artikel
|
| 21 |
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
|
Torlot, Lucien
|
|
|
149 |
2 |
p. 669-682
|
artikel
|
| 22 |
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study
|
Gursoy, Pınar
|
|
|
149 |
2 |
p. 865-875
|
artikel
|
| 23 |
Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration
|
Röhrmoser, Katharina
|
|
|
149 |
2 |
p. 803-810
|
artikel
|
| 24 |
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study
|
Lin, Xinqing
|
|
|
149 |
2 |
p. 757-764
|
artikel
|
| 25 |
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
|
Cao, Yanshuo
|
|
|
149 |
2 |
p. 779-789
|
artikel
|
| 26 |
The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study
|
Anic, Katharina
|
|
|
149 |
2 |
p. 851-863
|
artikel
|
| 27 |
The therapeutic effect of an autologous and allogenic mixed glioma cell lysate vaccine in a rat model
|
He, Haiping
|
|
|
149 |
2 |
p. 609-622
|
artikel
|
| 28 |
Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer
|
Pereira, Érica Romão
|
|
|
149 |
2 |
p. 567-577
|
artikel
|
| 29 |
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
|
Eckardt, Julia
|
|
|
149 |
2 |
p. 833-840
|
artikel
|
| 30 |
TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway
|
Chen, Jianping
|
|
|
149 |
2 |
p. 653-667
|
artikel
|
| 31 |
Treatment outcomes and prognostic factors in 47 patients with primary anorectal malignant melanoma in the immune therapy era
|
Ogata, Dai
|
|
|
149 |
2 |
p. 749-755
|
artikel
|
| 32 |
Tumor characteristics, therapy, and prognosis in young breast cancer patients ≤ 35 years
|
Eckardt, Naaja-Kristin
|
|
|
149 |
2 |
p. 709-719
|
artikel
|
Tijdschrift beschrijving